56 results
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
-intrusion, terrorism, or any escalation or worsening of any of the foregoing;
(E) any epidemic, pandemic (including COVID-19), disease outbreak or other
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
or terrorism, or any escalation or worsening of any of the foregoing, (E) any epidemic, pandemic (including COVID-19), disease outbreak or other public
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
or terrorism, or any escalation or worsening of any of the foregoing, (E) any epidemic, pandemic (including COVID-19), disease outbreak or other public
ARS
lgqeg85nl5kj27mm9
1 May 23
Annual report to shareholders
1:52pm
424B5
p9ewvi hgvz
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
6q8vxwmhsl bqs3i53
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B3
fqbbljfdon26
11 Jul 22
Prospectus supplement
4:32pm
POS AM
zgum06qo
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
606cqhhbc0dg1rt4w
1 Jul 22
Shelf registration
4:13pm
424B3
cocikb83sdj
13 May 22
Prospectus supplement
8:18am
424B3
ypwxuz1u971nqccb2b4d
31 Mar 22
Prospectus supplement
11:42am